BRIEF published on 04/02/2025 at 17:30, 1 year 1 month ago SOBRsafe Announces 1-for-10 Reverse Stock Split Reverse Stock Split Nasdaq Share Adjustment Equiniti Trust SOBR Safe
BRIEF published on 04/02/2025 at 17:30, 1 year 1 month ago SOBRsafe annonce un fractionnement d'actions inversé à raison de 1 pour 10 Nasdaq Regroupement D'actions Ajustement Des Actions Equiniti Trust Coffre-fort SOBR
PRESS RELEASE published on 04/02/2025 at 17:25, 1 year 1 month ago SOBRsafe Announces Reverse Stock Split SOBR Safe, Inc. announces 1-for-10 reverse stock split of Common Stock effective April 4, 2025. Equiniti Trust Company, LLC named exchange agent Reverse Stock Split Equiniti Equiniti Trust Company SOBR Safe, Inc. Transdermal Alcohol Detection
Published on 05/23/2026 at 03:15, 7 hours 31 minutes ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 7 hours 46 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 8 hours 21 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 8 hours 21 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 9 hours 46 minutes ago LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/22/2026 at 22:05, 12 hours 41 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 12 hours 41 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 14 hours 55 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 16 hours 13 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 16 hours 16 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 15 hours 11 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 16 hours 41 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 16 hours 41 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 21 hours 54 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 21 hours 54 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
